SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)
$19.78 0.11 (0.5592%)
Analysed SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) News Sources
Silence Therapeutics (SLN) Upgraded to Buy: Here's Why
13-10-2026
yahoo.com
Silence Therapeutics (SLN) Loses 28.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
14-10-2026
yahoo.com
Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany
19-10-2026
yahoo.com
Silence Therapeutics stock soars 125% on Merck acquisition
19-10-2026
yahoo.com
Silence Therapeutics jumps 59% on Merck takeover
19-10-2026
proactiveinvestors.com
Merck KgaA Is Paying More Than Double for This Gene-Silencing Biotech, Which Is Soaring 125%
19-10-2026
yahoo.com
Silence Therapeutics (SLN) Gets 130% Premium Offer From Merck, Shares Surge Over 100%
19-10-2026
yahoo.com
Is Silence Therapeutics (NasdaqGM:SLN) Reasonable Near Its $20 Deal Price?
20-10-2026
yahoo.com
Does Silence Therapeutics (SLN) Have the Potential to Rally 82.84% as Wall Street Analysts Expect?
20-10-2026
yahoo.com
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
20-10-2026
yahoo.com
What is the current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The current price of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is $19.78.
SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is $0.11.
SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) since the previous trading day is 0.5592%.
What is the most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The most recent average sentiment score for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)?
The most recent sentiment for SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ) is .
SEC-8K** Filing Available For SILENCE THERAPEUTICS PLC-ADR (SLN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.